SCHEMBL484572

SCHEMBL484572

COC(=O)c1ccc2c(c1)/C(=N\O)CC2(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.44
CYP3A4 P08684 3/20 0.44
CYP26A1 O43174 2/20 0.44
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
XDH P47989 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
MAPT P10636 4/20 0.39
CASP3 P42574 1/20 0.39
HSD17B10 Q99714 3/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
ATM Q13315 2/20 0.38
HPGD P15428 2/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484573 1.00 PDK2 (0.44) PDK2CYP3A4CYP26A1CA12CA1
SCHEMBL803934 1.00 PDK2 (0.44) PDK2CYP3A4CYP26A1CA12CA1
SCHEMBL803657 0.81 PDK2 (0.47) PDK2CYP3A4CYP26A1CA12CA1
SCHEMBL13131197 0.78 PDK2 (0.41) PDK2CYP3A4CYP26A1CA12CA1
SCHEMBL14996538 0.78 PDK2 (0.41) PDK2CYP3A4CYP26A1CA12CA1
SCHEMBL803507 0.75 MAPK14 (0.44) PDK2CA12CA1CA2CA7
SCHEMBL13131193 0.75 MAPK14 (0.44) PDK2CA12CA1CA2CA7
SCHEMBL17276101 0.73 MAPT (0.44) CA12CA1CA2CA7XDH
SCHEMBL6292717 0.73 CYP3A4 (0.48) PDK2CYP3A4CYP26A1CA12CA1
SCHEMBL4456893 0.73 MAPT (0.44) CA12CA1CA2CA7XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN PDK2 1271/4885CYP3A4 3781/4885CYP26A1 2640/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN PDK2 1271/4885CYP3A4 3781/4885CYP26A1 2640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.